Argen Financial Statements From 2010 to 2024
| ARGX Stock | EUR 582.60 17.80 3.15% |
Check Argen X financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Argen X's main balance sheet or income statement drivers, such as , as well as many indicators such as . Argen financial statements analysis is a perfect complement when working with Argen X Valuation or Volatility modules.
Argen |
Argen X Company Shares Outstanding Analysis
Argen X's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Argen X Shares Outstanding | 55.47 M |
Most of Argen X's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Argen X is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Argen X has 55.47 M of shares currently outstending. This is 69.27% lower than that of the Biotechnology sector and 48.09% lower than that of the Health Care industry. The shares outstanding for all Belgium stocks is 90.3% higher than that of the company.
Argen X Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Argen X's current stock value. Our valuation model uses many indicators to compare Argen X value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Argen X competition to find correlations between indicators driving Argen X's intrinsic value. More Info.Argen X is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Argen X's earnings, one of the primary drivers of an investment's value.About Argen X Financial Statements
Argen X shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Argen X investors may analyze each financial statement separately, they are all interrelated. The changes in Argen X's assets and liabilities, for example, are also reflected in the revenues and expenses on on Argen X's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. ARGENX SE operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 650 people.
Pair Trading with Argen X
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Argen X position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Argen X will appreciate offsetting losses from the drop in the long position's value.Moving against Argen Stock
| 0.9 | CFEB | Compagnie d Entreprises | PairCorr |
| 0.87 | BEKB | NV Bekaert SA | PairCorr |
| 0.81 | BNB | Banque nationale | PairCorr |
| 0.32 | UMI | Umicore SA | PairCorr |
The ability to find closely correlated positions to Argen X could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Argen X when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Argen X - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Argen X to buy it.
The correlation of Argen X is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Argen X moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Argen X moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Argen X can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Argen Stock Analysis
When running Argen X's price analysis, check to measure Argen X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argen X is operating at the current time. Most of Argen X's value examination focuses on studying past and present price action to predict the probability of Argen X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argen X's price. Additionally, you may evaluate how the addition of Argen X to your portfolios can decrease your overall portfolio volatility.